Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2007-4-24
pubmed:abstractText
HMG-CoA reductase inhibitors play several roles in the maintenance of organ transplants. We investigated the role of pitavastatin, a potent and newly developed HMG-CoA reductase inhibitor, in cardiac allograft rejection and mechanism of graft arterial disease (GAD) suppression.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0041-1337
pubmed:author
pubmed:issnType
Print
pubmed:day
27
pubmed:volume
83
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1093-7
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:17452900-Acute Disease, pubmed-meshheading:17452900-Animals, pubmed-meshheading:17452900-Cell Proliferation, pubmed-meshheading:17452900-Cholesterol, pubmed-meshheading:17452900-Chronic Disease, pubmed-meshheading:17452900-Cytokines, pubmed-meshheading:17452900-Gene Expression Regulation, pubmed-meshheading:17452900-Graft Rejection, pubmed-meshheading:17452900-Graft Survival, pubmed-meshheading:17452900-Heart Transplantation, pubmed-meshheading:17452900-Immunosuppressive Agents, pubmed-meshheading:17452900-Lymphocyte Culture Test, Mixed, pubmed-meshheading:17452900-Male, pubmed-meshheading:17452900-Mice, pubmed-meshheading:17452900-Myocytes, Smooth Muscle, pubmed-meshheading:17452900-Quinolines, pubmed-meshheading:17452900-Spleen, pubmed-meshheading:17452900-Survival Rate, pubmed-meshheading:17452900-Transplantation, Homologous, pubmed-meshheading:17452900-Triglycerides
pubmed:year
2007
pubmed:articleTitle
Pitavastatin suppresses acute and chronic rejection in murine cardiac allografts.
pubmed:affiliation
Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan. jsuzuki.cvm@tmd.ac.jp
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't